VIOL Future Growth
Future criteria checks 5/6
VIOL is forecast to grow earnings and revenue by 27.9% and 26.5% per annum respectively. EPS is expected to grow by 28% per annum. Return on equity is forecast to be 35.1% in 3 years.
Key information
27.9%
Earnings growth rate
28.0%
EPS growth rate
Medical Equipment earnings growth | 35.6% |
Revenue growth rate | 26.5% |
Future return on equity | 35.1% |
Analyst coverage | Good |
Last updated | 14 Nov 2024 |
Recent future growth updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 96,820 | 46,080 | 38,350 | 38,525 | 5 |
12/31/2025 | 77,130 | 38,253 | 35,933 | 37,100 | 6 |
12/31/2024 | 56,940 | 30,175 | 28,700 | 26,775 | 5 |
12/31/2023 | 43,166 | 21,854 | 18,167 | 20,825 | 5 |
3/31/2023 | 35,487 | 14,290 | 14,268 | 14,982 | N/A |
12/31/2022 | 31,108 | 11,473 | 10,699 | 11,229 | N/A |
9/30/2022 | 27,204 | 10,832 | 9,246 | 9,965 | N/A |
6/30/2022 | 24,183 | 7,963 | 8,479 | 9,823 | N/A |
3/31/2022 | 20,728 | 5,451 | 7,168 | 8,640 | N/A |
12/31/2021 | 18,373 | 4,437 | 6,126 | 7,967 | N/A |
9/30/2021 | 14,478 | -3,188 | 4,137 | 5,635 | N/A |
6/30/2021 | 11,723 | -4,334 | 1,750 | 2,443 | N/A |
3/31/2021 | 11,034 | -3,106 | -1,369 | 456 | N/A |
12/31/2020 | 12,154 | -1,811 | -1,875 | -383 | N/A |
12/31/2018 | 6,336 | 781 | 214 | 624 | N/A |
12/31/2017 | 7,123 | 1,924 | 528 | 1,083 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: A335890's forecast earnings growth (27.9% per year) is above the savings rate (2.7%).
Earnings vs Market: A335890's earnings (27.9% per year) are forecast to grow slower than the KR market (28% per year).
High Growth Earnings: A335890's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: A335890's revenue (26.5% per year) is forecast to grow faster than the KR market (9.3% per year).
High Growth Revenue: A335890's revenue (26.5% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: A335890's Return on Equity is forecast to be high in 3 years time (35.1%)